Laboratory for Advanced Medicine launches AI-based cancer test

Laboratory for Advanced Medicine (LAM) Inc. (Irvine, Calif.) launched IvyGene, a non-invasive epigenetic blood test to confirm and diagnose breast, colon, liver and lung cancer, with select U.S. doctors.

IvyGene uses artificial intelligence and machine learning technologies to identify DNA methylation patterns associated with tumor DNA in patient blood samples. According to Shu Li, LAM's chairman, cancer-associated DNA methylation patterns are more stable and accurate markers of cancer than DNA mutations and can be observed in both tissue and blood...